2017-07-24T16:35:04
Long-Acting Injectable HIV Regimens Show Promise Long-acting injectable therapy for HIV appears to maintain viral suppression as effectively as daily oral treatment, according to an international, industry-funded, phase 2b trial. The results were presented on Monday at the International AIDS Society annual meeting and published in the Lancet